Lv62
2030 积分 2023-05-24 加入
〈1154〉 Liposome Drug Products
2个月前
已关闭
〈1154〉 Liposome Drug Products
2个月前
已关闭
Profiling in-vitro release of verteporfin from VISUDYNE® liposomal formulation and investigating verteporfin binding to human serum albumin
3个月前
已完结
A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment
3个月前
已完结
Analysis of verteporfin liposomal formulations for phospholipids and phospholipid degradation products by liquid chromatography-mass spectrometry (LC-MS)
3个月前
已完结
Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS)
3个月前
已完结
Excipient-related impurities in liposome drug products
3个月前
已完结
Reverse engineering of Onivyde® – Irinotecan liposome injection
3个月前
已完结
Artificial cells with liquid–liquid phase separation–regulated cell-free protein synthesis
5个月前
已完结
Biomaterials with droplet microfluidics
6个月前
已完结
皖公网安备34019202002308
